Influence of Segment Shape Optimization Parameter in Radiotherapy Volumetric Modulated Arc Therapy Planning of Cervical Cancer

被引：0

作者：

Jain, Nidhi ^{[1
]}

Kumar, Alok ^{[2
]}

Kumar, Ashok ^{[1
]}

机构：

[1] Department of Physics, AIAS, Amity University, U.P.

[2] Department of Radiation Oncology, Netaji Subhas Chandra Bose Cancer Hospital and Institute, West Bengal, Kolkata

来源：

Iranian Journal of Medical Physics | 2024年 / 21卷 / 04期

关键词：

Cervical Cancer; Sequencing Parameter; Therapy; VMAT; Volumetric Modulated Arc;

D O I：

10.22038/ijmp.2023.69271.2220

中图分类号：

学科分类号：

摘要：

Introduction: The aim of this study is to find out the influence of different Segment shape optimization (SSO) parameters in radiotherapy Volumetric Modulated Arc therapy (VMAT) planning of Cervical Cancer and to find out the optimized value for cervical cancer patients. Material and Methods: It was a retrospective study of 20 Ca cervix patients. Every patient had six plans named SL1, SL5, SL10, SL15, SL20, and NSL. In each case, the value of the shaping loop will be changed during the VMAT plan, while the other optimization parameters and constraint functions will remain the same in each case. All Dosimetric parameters have been measured and analysed for Planning Target Volume (PTV) and Organ at risk (OAR) dose, Monitor Unit (MU), memory, Plan Delivery Time (PDT), and Gamma Passing Rate (GPR) for comparison purposes. Results: In NSL cases, the PTV dose derived from the DVH did not meet the clinical standards D95% = 86.8% (<95%) with a poorer homogeneity index (HI = 0.2). As the SL value increases, plan quality increases, monitor units increase slightly and plan delivery time decreases while there is a parallel increase in memory consumption. There is no statistical difference in target dose and OAR dose between the SL5 and SL1 plans (P > 0.05) compared with the other groups. SL5 has the least plan memory compared to other SL values. Conclusion: Based on the plan quality, the dose accuracy, and the efficiency of delivery, SL1 and SL5 have similar characteristics in cervical cancer cases. Both SL1 and SL5 values should recommend for cervical cancer VMAT planning. © (2024), (Mashhad University of Medical Sciences). All rights reserved.

引用

页码：258 / 264

页数：6

共 25 条

[21]

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: a cancer journal for clinicians, 71, 3, pp. 209-249, (2021)

[22]

Yang J, Cai H, Xiao ZX, Wang H, Yang P., Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database, Medicine (Baltimore), 98, 30, (2019)

[23]

Chino J, Annunziata CM, Beriwal S, Et al., Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline, Pract Radiat Oncol, 10, 4, pp. 220-234, (2020)

[24]

Faye MD, Alfieri J., Advances in Radiation Oncology for the Treatment of Cervical Cancer, Current Oncology, 29, 2, pp. 928-944, (2022)

[25]

Ezzell GA, Burmeister JW, Dogan N, Et al., IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119, Med Phys, 36, 11, pp. 5359-5373, (2009)

← 1 2 3 →